This company has been marked as potentially delisted and may not be actively trading. CNSX:MPX MPX Bioceutical (MPX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About MPX Bioceutical Stock (CNSX:MPX) 30 days 90 days 365 days Advanced Chart Get MPX Bioceutical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MPX Bioceutical Corporation is a multinational diversified cannabis company focused on the medical and adult use cannabis markets. The company has a growing presence in the U.S. with imminent plans for ten dispensaries and four production facilities in four states. It also has a production facility under construction in Canada as well as a pending licence application to Health Canada. Read More Receive MPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MPX Bioceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address MPX Stock News HeadlinesMPX Bioceutical Corporation (5CB.F)August 12, 2024 | nz.finance.yahoo.comMarine Products (NYSE:MPX) Will Want To Turn Around Its Return TrendsMay 22, 2024 | finance.yahoo.comBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. August 25 at 2:00 AM | Crypto 101 Media (Ad)Marine Products Corp (MPX) Q1 2024 Earnings Call Transcript Highlights: Navigating Market ...April 26, 2024 | finance.yahoo.comMarine Products First Quarter 2024 Earnings: EPS: US$0.13 (vs US$0.34 in 1Q 2023)April 26, 2024 | finance.yahoo.comQ1 2024 Marine Products Corp Earnings CallApril 25, 2024 | finance.yahoo.comAt US$10.64, Is Marine Products Corporation (NYSE:MPX) Worth Looking At Closely?February 19, 2024 | finance.yahoo.comMarine Products (NYSE:MPX) Could Be A Buy For Its Upcoming DividendFebruary 3, 2024 | finance.yahoo.comSee More Headlines MPX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of MPX Bioceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that MPX Bioceutical investors own include CAMP4 Therapeutics (CAMP), Canopy Growth (CGC), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Nemaska Lithium (NMX), Unrivaled Brands (TRTC) and CrowdStrike (CRWD). Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis Current SymbolCNSX:MPX CIKN/A Webcanadianbioceutical.com Phone+1-416-840-3725FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (CNSX:MPX) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MPX Bioceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share MPX Bioceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.